Literature DB >> 24371553

Peritoneal macrophages from patients with cirrhotic ascites show impaired phagocytosis and vigorous respiratory burst.

Abdel Motaal M Ahmed1, Adrian Bomford1, Kayhan T Nouri-Aria1, Ted Davies1, Roger Smith1, Roger Williams2.   

Abstract

Cirrhotic patients (CPs) are susceptible to spontaneous bacterial peritonitis (SBP). Aim of this study was to examine if this susceptibility was related to peritoneal macrophages' (PMs) altered host defence. Absorbance of phagocytosed particles by PMs from CPs was lower than that of control (31.88% vs. 77.2%). Particle opsonisation increased the absorbance to 41% in CPs' PMs, and this value remains lower than the control; 77.2%. Respiratory burst (RB) was expressed as fluorescence index values, and these were higher in PMs from CPs than in controls (82 vs. 41, 73 vs. 26 and 71 vs. 26). IFN-γ made no further increase of RB values in PMs from CPs. CD14 expression was also higher in CPs' PMs. IFN-γ significantly downregulated CD14 expression in both CPs' PMs and control. Reduced phagocytosis by predominantly CD14-positive PMs from CPs could be related to intense RB. Findings suggest altered host defence that could contribute to susceptibility to SBP.

Entities:  

Keywords:  CD14 expression; Peritoneal macrophages; Respiratory burst; Spontaneous bacterial peritonitis; Yeast phagocytosis

Year:  2011        PMID: 24371553      PMCID: PMC3787812          DOI: 10.1016/j.rinim.2011.08.004

Source DB:  PubMed          Journal:  Results Immunol        ISSN: 2211-2839


  33 in total

Review 1.  Colony-stimulating factors and host defense.

Authors:  R H Weisbart; J C Gasson; D W Golde
Journal:  Ann Intern Med       Date:  1989-02-15       Impact factor: 25.391

2.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

3.  Impaired opsonization by serum from patients with chronic liver disease.

Authors:  R J Wyke; I A Rajkovic; R Williams
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

4.  Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1983-05       Impact factor: 3.487

5.  Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages.

Authors:  L Maródi; H M Korchak; R B Johnston
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

6.  Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa.

Authors:  D P Speert; S D Wright; S C Silverstein; B Mah
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  The effects of interferon-gamma and bacterial lipopolysaccharide on CD14 expression in human monocytes.

Authors:  J B Payne; F C Nichols; J F Peluso
Journal:  J Interferon Res       Date:  1992-08

8.  Human resident peritoneal macrophages: phenotype and biology.

Authors:  A Eischen; B Duclos; M Schmitt-Goguel; N Rouyer; J P Bergerat; M Hummel; R Oskam; F Oberling
Journal:  Br J Haematol       Date:  1994-12       Impact factor: 6.998

9.  Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism.

Authors:  M E Wilson; R D Pearson
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

10.  Superoxide release by peritoneal and bone marrow-derived mouse macrophages. Modulation by adherence and cell activation.

Authors:  G Berton; S Gordon
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

View more
  6 in total

Review 1.  Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting.

Authors:  Arjuna Singanayagam; Evangelos Triantafyllou
Journal:  Front Immunol       Date:  2021-04-02       Impact factor: 7.561

2.  Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor.

Authors:  Abdel Motaal M Ahmed; Abdel Gadir Y Kadaru; Ibtihal Omer; Ahmed M Musa; Khalid Enan; Isam M El Khidir; Roger Williams
Journal:  J Clin Exp Hepatol       Date:  2014-09-16

Review 3.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

4.  Ascites' neutrophil function is significantly impaired in patients with decompensated cirrhosis but can be restored by autologous plasma incubation.

Authors:  Cornelius Engelmann; Christina Becker; Andreas Boldt; Toni Herta; Albrecht Boehlig; Katrin Splith; Moritz Schmelzle; Niklas Mueller; Sandra Krohn; Hans-Michael Tautenhahn; Michael Bartels; Ulrich Sack; Thomas Berg
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

Review 5.  Causes and Consequences of Innate Immune Dysfunction in Cirrhosis.

Authors:  Katharine Margaret Irvine; Isanka Ratnasekera; Elizabeth E Powell; David Arthur Hume
Journal:  Front Immunol       Date:  2019-02-25       Impact factor: 7.561

6.  Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis.

Authors:  Ping An; Lin-Lin Wei; Shuangshuang Zhao; Deanna Y Sverdlov; Kahini A Vaid; Makoto Miyamoto; Kaori Kuramitsu; Michelle Lai; Yury V Popov
Journal:  Nat Commun       Date:  2020-05-12       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.